Citations

Clear

4093 citation(s) found for "Yu, Jonathan".

A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk
Dicanio, Marco, Giaccherini, Matteo , Clay‐Gilmour, Alyssa , Macauda, Angelica , Sáinz, Juan , Machiela, Mitchell J. , Rybicka‐Ramos, Malwina, Barington, Torben , Kumar, Shaji , Bhatti, Parveen , Brown, Elizabeth E. , Haastrup, Eva, Orlowski, Robert Z. , Dudziński, Marek , García‐Sánz, Ramón , Kruszewski, Marcin , Martínez‐López, Joaquín , Beider, Katia , Iskierka‐Jazdzewska, Elżbieta , Pelosini, Matteo , Berndt, Sonja I. , Raźny, Małgorzata , Collado, Pilar, Petrini, Mario , Butrym, Aleksandra , Ziv, Elad , Andersen, Niels Frost, Mazur, Grzegorz , Wątek, Marzena , Zawirska, Daria , Ebbesen, Lene Hyldahl, Gemignani, Federica , Várkonyi, Judit , Buda, Gabriele , Nagler, Arnon, Druzd‐Sitek, Agnieszka , Wu, Xifeng , Kádár, Katalin , Camp, Nicola J. , Grząśko, Norbert , Waller, Rosalie, Vachon, Celine M. , Campa, Daniele , Martinez-Lopez, Joaquin , Waller, Rosalie G. , Griffin, R. L. , Beider, Katia , Lesueur, Fabienne , Hildebrandt, Michelle A T , Vachon, Celine, Campa, Daniele , Orlowski, Robert Z. , Martinez-Lopez, Joaquin , Butrym, Aleksandra , Garcia-Sanz, Ramon , Bhatti, Parveen , Ziv, Elad , Waller, Rosalie G , Machiela, Mitchell J , Sainz, Juan , Watek, Marzena , Iskierka-Jazdzewska, Elżbieta , Martinez-Lopez, Joaquin , Mazur, Grzegorz , Giaccherini, Matteo , Griffin, Rosalie , Norman, Aaron D. , Tyczyńska, Agata , Chanock, Stephen Jacob , Cozen, Wendy , Suska, Anna , Jamroziak, Krzysztof , Rajkumar, S. Vincent , Jurczyszyn, Artur , Vangsted, Annette Juul , Collado, Pilar Garrido, Vogel, Ulla , Hofmann, Jonathan N. , Slager, Susan L. , Subocz, Edyta , Giles, Graham G. , Lesueur, Fabienne , Hildebrandt, Michelle A.T. , Marques, Herlander , Dumontet, Charles , Nagler, Arnon , Vachon, Celine M. , Canzian, Federico

Mayo Clinic

International Journal of Cancer | September 9, 2022 | Volume: 152 | Issue: 2 | Pages: 239-248

10.1002/ijc.34278 | PMID 36082445 Get It

AbstractPleiotropy, which consists of a single gene or allelic variant affecting multiple unrelated traits, is common across cancers, with evidence for genome‐wide significant loci shared across cancer and noncancer traits. This feature is particularly relevant in multiple myeloma (MM) because several susceptibility loci that have been identified to date are pleiotropic. Therefore, the aim of this study was to identify novel pleiotropic variants involved in MM risk using 28 684 independent single nucleotide polymorphisms (SNPs) from GWAS Catalog that reached a significant association (P < 5 × 10−8) with their respective trait. The selected SNPs were analyzed in 2434 MM cases and 3446 controls from the International Lymphoma Epidemiology Consortium (InterLymph). The 10 SNPs showing the strongest associations with MM risk in InterLymph were selected for replication in an independent set of 1955 MM cases and 1549 controls from the International Multiple Myeloma rESEarch (IMMEnSE) consortium and 418 MM cases and 147 282 controls from the FinnGen project. The combined analysis of the three studies identified an association between DNAJB4‐rs34517439‐A and an increased risk of developing MM (OR = 1.22, 95%CI 1.13‐1.32, P = 4.81 × 10−7). rs34517439‐A is associated with a modified expression of the FUBP1 gene, which encodes a multifunctional DNA and RNA‐binding protein that it was observed to influence the regulation of various genes involved in cell cycle regulation, among which various oncogenes and oncosuppressors. In conclusion, with a pleiotropic scan approach we identified DNAJB4‐rs34517439 as a potentially novel MM risk locus.
Sinus Tachycardia: a Multidisciplinary Expert Focused Review
Mayuga, Kenneth A. , Fedorowski, Artur , Ricci, Fabrizio , Gopinathannair, Rakesh , Dukes, Jonathan W., Hanna, Peter , Sorajja, Dan , Chung, Mina K. , Benditt, David G. , Sheldon, Robert S. , Ayache, Mirna , AbouAssi, Hiba, Shivkumar, Kalyanam , Hamdan, Mohamed H. , Stavrakis, Stavros , Singh, Tamanna , Muldowney, James A.S. , Belham, Mark , Kem, David C. , Bruce, Barbara K. , Zahka, Nicole E. , Fu, Qi , Iterson, Erik H. Van , Fouad-Tarazi, Fetnat M., Stewart, Julian M. , Hanna, Peter , Sorajja, Dan , Chung, Mina , Benditt, David , Sheldon, Robert , Shivkumar, Kalyanam , Stavrakis, Stavros , Singh, Tamanna , Goldberger, Jeffrey J , Muldowney, James A S , Belham, Mark , Kem, David C , Akin, Cem , Bruce, Barbara K , Zahka, Nicole E , Fu, Qi , Van Iterson, Erik H , Raj, Satish R , Stewart, Julian , Olshansky, Brian , Fedorowski, Artur , Gopinathannair, Rakesh , Ricci, Fabrizio , Gibbons, Christopher H. , Grubb, Blair P. , Akin, Cem , Goldstein, David S. , Olshansky, Brian

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | September 8, 2022 | Volume: 15 | Issue: 9 | Pages: No page available

10.1161/circep.121.007960 | PMID 36074973 Get It

Sinus tachycardia (ST) is ubiquitous, but its presence outside of normal physiological triggers in otherwise healthy individuals remains a commonly encountered phenomenon in medical practice. In many cases, ST can be readily explained by a current medical condition that precipitates an increase in the sinus rate, but ST at rest without physiological triggers may also represent a spectrum of normal. In other cases, ST may not have an easily explainable cause but may represent serious underlying pathology and can be associated with intolerable symptoms. The classification of ST, consideration of possible etiologies, as well as the decisions of when and how to intervene can be difficult. ST can be classified as secondary to a specific, usually treatable, medical condition (eg, pulmonary embolism, anemia, infection, or hyperthyroidism) or be related to several incompletely defined conditions (eg, inappropriate ST, postural tachycardia syndrome, mast cell disorder, or post-COVID syndrome). While cardiologists and cardiac electrophysiologists often evaluate patients with symptoms associated with persistent or paroxysmal ST, an optimal approach remains uncertain. Due to the many possible conditions associated with ST, and an overlap in medical specialists who see these patients, the inclusion of experts in different fields is essential for a more comprehensive understanding. This article is unique in that it was composed by international experts in Neurology, Psychology, Autonomic Medicine, Allergy and Immunology, Exercise Physiology, Pulmonology and Critical Care Medicine, Endocrinology, Cardiology, and Cardiac Electrophysiology in the hope that it will facilitate a more complete understanding and thereby result in the better care of patients with ST.
Anteroinferior Glenoid Rim Fractures Are a Relatively Common Finding in Shoulder Instability Patients Aged 50 Years or Older but May Not Portend a Worse Prognosis
Song, Bryant M. , Smartt, Anne A. , Wilbur, Ryan R. , Krych, Aaron J. , Okoroha, Kelechi R. , Camp, Christopher L. , Camp, Christopher L. , Krych, Aaron J , Barlow, Jonathan D.

Mayo Clinic

Arthroscopy, Sports Medicine, and Rehabilitation | September 8, 2022 | Volume: 4 | Issue: 5 | Pages: No page available

10.1016/j.asmr.2022.07.012 | PMID 36312703 Get It

Purpose To investigate the incidence of anteroinferior glenoid rim fractures (AGRFs) after anterior shoulder instability (ASI) in patients aged 50 years or older, identify risk factors for surgical intervention for AGRFs, compare initial treatment strategies, and compare clinical outcomes of patients with and without associated AGRFs. Methods An established geographic medical record system was used to identify patients aged 50 years or older with ASI between 1994 and 2016. Patients with radiographic evidence of AGRFs were identified and matched 1:1 to patients without AGRFs. Outcome measures included recurrent instability, recurrent pain events, conversion to arthroplasty, and osteoarthritis graded with the Samilson‐Prieto classification for post‐instability arthritis. Results Overall, 177 patients were identified, with a mean follow‐up period of 10.8 years. Of these patients, 41 (23.2%) had AGRFs and were matched to 41 control patients without AGRFs. The average age was 58.6 and 58.2 years for the AGRF and control groups, respectively. Rates of surgical intervention (27% vs 49%), recurrent instability (12% vs 20%), progression of osteoarthritis (34% vs 39%), and conversion to arthroplasty (2% vs 5%) were similar between AGRF patients and controls. For patients with AGRFs, increased bone fragment size (odds ratio, 1.1) and increased body mass index (odds ratio, 1.2) correlated with an increased risk of surgery. The cutoff value for an increased risk of surgery in patients with AGRFs was a fragment size 33% of the glenoid width or greater. Conclusions Of patients aged 50 years or older at presentation of ASI, 23.2% presented with an associated AGRF. A fragment size 33% of the glenoid width or greater and a higher patient body mass index were significant factors for surgical intervention; however, most patients did not require surgery and still showed acceptable clinical outcomes, and the most common reason for surgical intervention was a rotator cuff tear. Overall, the presence of an AGRF did not portend a worse prognosis as treatment strategies and long‐term outcomes including recurrent instability, progression of osteoarthritis, and conversion to arthroplasty were similar to those in patients without AGRFs. Level of Evidence Level III, retrospective comparative study.
Incidence Of Illness Among Team USA Athletes During The Tokyo 2020 Summer Olympic Games
Clark, Stephanie C., Cali, Malia G. , Hasley, Ike B., Larson, Emily G., Noble-Taylor, Kayle E., Adams, William M. , McPherson, April L. , Robinson, David M. , Finnoff, Jonathan T.

Mayo Clinic

Medicine & Science in Sports & Exercise | September 6, 2022 | Volume: 54 | Issue: 9S | Pages: 666-666

10.1249/01.mss.0000883384.82776.bd Get It

Incidence Of Injuries Among Team USA Athletes Competing In Tokyo 2020 Summer Olympic Games
Noble-Taylor, Kayle E., Cali, Malia G. , Clark, Stephanie C., Hasley, Ike B., Larson, Emily G., Adams, William M. , McPherson, April L. , Robinson, David M. , Finnoff, Jonathan T.

Mayo Clinic

Medicine & Science in Sports & Exercise | September 6, 2022 | Volume: 54 | Issue: 9S | Pages: 666-666

10.1249/01.mss.0000883380.16252.a0 Get It

Incidence Of Illness Among Team USA Paralympic Athletes Competing In The Tokyo 2020 Paralympic Games
Cali, Malia G. , Clark, Stephanie C., Hasley, Ike B., Larson, Emily G., Noble-Taylor, Kayle E., Robinson, David M. , Adams, William M. , Clark, Stephanie C., McPherson, April L. , Finnoff, Jonathan T.

Mayo Clinic

Medicine & Science in Sports & Exercise | September 6, 2022 | Volume: 54 | Issue: 9S | Pages: 665-666

10.1249/01.mss.0000883376.63356.62 Get It

Incidence Of Team USA Staff Illnesses And Injuries During The Tokyo 2020 Summer Paralympic Games
Larson, Emily G., Cali, Malia G. , Clark, Stephanie C., Hasley, Ike B., Noble-Taylor, Kayle E., Adams, William M. , McPherson, April L. , Robinson, David M. , Finnoff, Jonathan T.

Mayo Clinic

Medicine & Science in Sports & Exercise | September 6, 2022 | Volume: 54 | Issue: 9S | Pages: 665-665

10.1249/01.mss.0000883368.14934.d2 Get It

Incidence Of Injuries And Illnesses Among Team USA Staff During The Tokyo 2020 Summer Olympic Games
Hasley, Ike B., Cali, Malia G. , Clark, Stephanie C., Larson, Emily G., Noble-Taylor, Kayle E., Adams, William M. , Clark, Stephanie C., McPherson, April L. , Robinson, David M. , Finnoff, Jonathan T.

Mayo Clinic

Medicine & Science in Sports & Exercise | September 6, 2022 | Volume: 54 | Issue: 9S | Pages: 664-664

10.1249/01.mss.0000883360.94384.a1 Get It

Incidence Of Injuries Among Us Paralympic Athletes Competing In The Tokyo 2020 Paralympic Games
Cali, Malia G. , Clark, Stephanie C., Hasley, Ike B., Larson, Emily G., Noble-Taylor, Kayle E., Robinson, David M. , Adams, William M. , Clark, Stephanie C., McPherson, April L. , Robinson, David M., Finnoff, Jonathan T.

Mayo Clinic

Medicine & Science in Sports & Exercise | September 6, 2022 | Volume: 54 | Issue: 9S | Pages: 323-324

10.1249/01.mss.0000879076.41289.8f Get It